Price
No data yet.
Social Signal Score
Analyst Ratings
2 analystsRevenue
$4.26B+237.98%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Jean-Christophe Tellier
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 10,117
- Beta
- 0.20
- Country
- BE
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 4.77
Financials
Revenue
$4.26B+238.0%Net Income
$1.11B+504.5%EBITDA
$1.73B+411.3%Free Cash Flow
$82.88M-13.2%EPS (diluted)
$5.72+130.6%Shares Outstanding (diluted)
193.95M+162.6%Operating Expenses
$2.15BCash & Debt
$795.81MReturn of Capital
$402.40MDividend per Share
$1.70Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $7.74B | $1.56B | $8.20 |
| 2024 | $6.15B | $1.06B | $5.61 |
| 2023 | $5.25B | $343.00M | $1.81 |
| 2022 | $5.52B | $418.00M | $2.20 |
| 2021 | $5.78B | $1.06B | $5.60 |
| 2020 | $5.35B | $732.00M | $3.87 |
| 2019 | $4.91B | $792.00M | $4.23 |
| 2018 | $4.63B | $800.00M | $8.49 |
| 2017 | $4.53B | $753.00M | $8.00 |
| 2016 | $4.18B | $520.00M | $5.52 |
| 2015 | $3.88B | $623.00M | $6.50 |
| 2014 | $3.34B | $209.00M | $2.20 |
| 2013 | $3.41B | $160.00M | $1.76 |
| 2012 | $3.46B | $249.00M | $2.78 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from UCBJF's reported EPS growth of 8.7% a year over 13 years.
- EPS in 5 years
- $12.44
- Implied price
- $373.18
- Return from $238.54
- 9.4% a year
To earn 15.0% a year on these assumptions you'd need to buy at $185.54 — -22.2% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 20 | 25 | 30 | 35 | 40 |
|---|---|---|---|---|---|
| -1.3% | -8.4% | -4.3% | -0.7% | 2.4% | 5.2% |
| 3.7% | -3.8% | 0.6% | 4.3% | 7.6% | 10.5% |
| 8.7% | 0.8% | 5.4% | 9.4% | 12.8% | 15.8% |
| 13.7% | 5.5% | 10.3% | 14.4% | 18.0% | 21.2% |
| 18.7% | 10.1% | 15.1% | 19.4% | 23.2% | 26.5% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
70+0.00%Social Signal Score
Mentions (8)
- Newszacks.com·4d ago·Positive
Why United Community Banks (UCB) is a Great Dividend Stock Right Now Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does United Community Banks (UCB) have what it takes?
View source ↗ - Newsseekingalpha.com·12d ago·Positive
UCB SA (UCBJY) Presents at J.P. Morgan CEO Call Series Transcript UCB SA (UCBJY) Presents at J.P. Morgan CEO Call Series Transcript
View source ↗ - Newsseekingalpha.com·12d ago·Positive
UCB SA (UCBJY) Presents at Bank of America Global Healthcare Conference 2026 Transcript UCB SA (UCBJY) Presents at Bank of America Global Healthcare Conference 2026 Transcript
View source ↗ - Newszacks.com·17d ago·Positive
UCB (UCBJY) Upgraded to Buy: Here's Why UCB (UCBJY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
View source ↗ - Newszacks.com·20d ago·Positive
Why United Community Banks (UCB) is a Top Dividend Stock for Your Portfolio Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does United Community Banks (UCB) have what it takes?
View source ↗ - Newsseekingalpha.com·27d ago·Positive
United Community Banks, Inc. (UCB) Discusses Completion of Strategic Initiatives and Sale of Navitas to Strengthen Financial Position Transcript United Community Banks, Inc. (UCB) Discusses Completion of Strategic Initiatives and Sale of Navitas to Strengthen Financial Position Transcript
View source ↗ - Newszacks.com·39d ago·Positive
United Community Banks (UCB) is a Top Dividend Stock Right Now: Should You Buy? Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does United Community Banks (UCB) have what it takes?
View source ↗ - Newszacks.com·55d ago·Positive
United Community Banks (UCB) Could Be a Great Choice Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does United Community Banks (UCB) have what it takes?
View source ↗
Earnings
Thu, Feb 25(in 5 months)
Consensus estimate $5.88 per share
Typical surprise +18.5% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Jul 30$7.81 vs $5.81beat
- Thu, Feb 26$7.59 vs $5.83beat
- Thu, Jul 31$4.16 vs $3.89beat
- Thu, Feb 27$2.96 vs $2.68beat
- Thu, Jul 25$2.24 vs $1.89beat
- Wed, Feb 28$1.72 vs $1.48beat
Estimates and results for UCBJF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Congress trades
No disclosed congressional trades in UCBJF.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.